KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Non Operating Income: 2010-2024

Historic Non Operating Income for Neogenomics (NEO) over the last 14 years, with Dec 2024 value amounting to -$379,000.

  • Neogenomics' Non Operating Income fell 205.68% to -$335,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$219,000, marking a year-over-year decrease of 224.43%. This contributed to the annual value of -$379,000 for FY2024, which is 158.85% down from last year.
  • As of FY2024, Neogenomics' Non Operating Income stood at -$379,000, which was down 158.85% from $644,000 recorded in FY2023.
  • In the past 5 years, Neogenomics' Non Operating Income registered a high of $7.9 million during FY2020, and its lowest value of -$499,000 during FY2021.
  • For the 3-year period, Neogenomics' Non Operating Income averaged around $17,333, with its median value being -$213,000 (2022).
  • As far as peak fluctuations go, Neogenomics' Non Operating Income skyrocketed by 402.35% in 2023, and later crashed by 158.85% in 2024.
  • Yearly analysis of 5 years shows Neogenomics' Non Operating Income stood at $7.9 million in 2020, then crashed by 106.31% to -$499,000 in 2021, then soared by 57.31% to -$213,000 in 2022, then skyrocketed by 402.35% to $644,000 in 2023, then plummeted by 158.85% to -$379,000 in 2024.